Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Role of PLA2R and Anti-PLA2R in Idiopathic Membranous Nephropathy | Grant |
Why?
|
Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy? | Academic Article |
Why?
|
Refining Our Understanding of the PLA2R-Antibody Response in Primary Membranous Nephropathy: Looking Forward, Looking Back. | Academic Article |
Why?
|
Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy. | Academic Article |
Why?
|
Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era. | Academic Article |
Why?
|
Monoclonal anti-PLA2R and recurrent membranous nephropathy: another piece of the puzzle. | Academic Article |
Why?
|
PLA2R and THSD7A: Disparate Paths to the Same Disease? | Academic Article |
Why?
|
Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report. | Academic Article |
Why?
|
Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. | Academic Article |
Why?
|
Towards optimizing use of PLA2R antibody testing in membranous nephropathy. | Academic Article |
Why?
|
Anti-PLA2R Immunoreactivity | Grant |
Why?
|
Investigation of Anti-PLA2R-Associated Membranous Nephropathy at the Molecular Level | Grant |
Why?
|
Podocyte-specific human PLA2R transgenic mouse model of membranous nephropathy | Grant |
Why?
|
The latest model has just arrived! A new experimental mouse model of PLA2R1-associated membranous nephropathy. | Academic Article |
Why?
|
Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy. | Academic Article |
Why?
|